Business Segments — Selling and marketing expenses
Gilead Sciences Business Segments — Selling and marketing expenses decreased by 16.5% to $898.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.3%, from $753.00M to $898.00M. Over 3 years (FY 2022 to FY 2025), Business Segments — Selling and marketing expenses shows relatively stable performance with a 1.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase may indicate aggressive product launches or market expansion, while a decrease could suggest cost-cutting or a shift toward more efficient digital marketing strategies.
Detailed definition
This metric represents the costs incurred by the company to promote, advertise, and sell its pharmaceutical products to...
Peer comparison
Comparable to Selling, General, and Administrative (SG&A) marketing components at other large-cap pharmaceutical firms.
gild_segment_reportable_segment_selling_and_marketing_expensesHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $832.75M | $832.75M | $832.75M | $832.75M | $818.00M | $818.00M | $818.00M | $818.00M | $743.00M | $805.00M | $848.00M | $1.06B | $753.00M | $864.00M | $829.00M | $1.08B | $898.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -1.8% | +0.0% | +0.0% | +0.0% | -9.2% | +8.3% | +5.3% | +24.6% | -28.8% | +14.7% | -4.1% | +29.8% | -16.5% |
| YoY Change | — | — | — | — | -1.8% | -1.8% | -1.8% | -1.8% | -9.2% | -1.6% | +3.7% | +29.2% | +1.3% | +7.3% | -2.2% | +1.8% | +19.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's business segments — selling and marketing expenses?
- Gilead Sciences (GILD) reported business segments — selling and marketing expenses of $898.00M in Q1 2026.
- How has Gilead Sciences's business segments — selling and marketing expenses changed year-over-year?
- Gilead Sciences's business segments — selling and marketing expenses increased by 19.3% year-over-year, from $753.00M to $898.00M.
- What is the long-term trend for Gilead Sciences's business segments — selling and marketing expenses?
- Over 3 years (2022 to 2025), Gilead Sciences's business segments — selling and marketing expenses has grown at a 1.9% compound annual growth rate (CAGR), from $3.33B to $3.52B.
- What does business segments — selling and marketing expenses mean?
- The total costs spent on marketing and selling the company's products.